Intensive Care News and Research RSS Feed - Intensive Care News and Research

3D printing technology can make heart surgery safer for children with congenital anomaly

3D printing technology can make heart surgery safer for children with congenital anomaly

Three-dimensional printing technology can make surgery safer for children with congenital heart disease and reduce the duration as well as the number of invasive procedures required. [More]
ICU patients using ventilators could benefit from assistive communication tools

ICU patients using ventilators could benefit from assistive communication tools

A new study reveals that more than half of patients in intensive care units (ICU) using ventilators to help them breathe could benefit from assistive communication tools. [More]
Morphine after tonsillectomy may be life threatening for children

Morphine after tonsillectomy may be life threatening for children

Treating post-operative pain with morphine can cause life-threatening respiratory problems in some children who have had their tonsils and/or adenoids removed, new research has found. [More]
Phase I of new Heart Hospital opens at MedStar Washington Hospital Center

Phase I of new Heart Hospital opens at MedStar Washington Hospital Center

An entire floor of the new Heart Hospital at MedStar Washington Hospital Center was dedicated earlier this month by MedStar Heart & Vascular Institute medical staff, associates and administrators. The opening of the new 60-bed unit marks the completion of Phase I of four phases in the construction of the first dedicated Heart Hospital in the nation's capital. [More]
Study: 20% of very-low-birth-weight babies born in California not referred for follow-up care

Study: 20% of very-low-birth-weight babies born in California not referred for follow-up care

The tiniest babies need special follow-up care when they go home from the hospital after birth. But, of the thousands of very-low-birth-weight babies born in California during 2010 and 2011, 20 percent were not referred to the state's high-risk infant follow-up program, according to a new study by researchers at the Stanford University School of Medicine. [More]
Voices of loved ones telling familiar stories can help awaken unconscious brain, speed coma recovery

Voices of loved ones telling familiar stories can help awaken unconscious brain, speed coma recovery

"Can he hear me?" family members are desperate to know when a loved one with a traumatic brain injury is in a coma. [More]
Astute Medical, bioMérieux sign agreement to develop NephroCheck Test for acute kidney injury

Astute Medical, bioMérieux sign agreement to develop NephroCheck Test for acute kidney injury

bioMérieux, a world leader in the field of in vitro diagnostics, and Astute Medical, Inc., a company dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers, today announced that they have signed a global, semi-exclusive agreement regarding the development of a test for the early risk assessment of acute kidney injury (AKI). [More]
Bathing critically ill patients with chlorhexidine wipes does not prevent ICU infections

Bathing critically ill patients with chlorhexidine wipes does not prevent ICU infections

Vanderbilt University Medical Center researchers have found that bathing critically ill patients with disposable chlorhexidine cloths did not decrease the incidence of health care-associated infections when compared to less expensive nonantimicrobial cloths, according to a study appearing online in JAMA this week. [More]
Urinary levels of novel biomarkers linked to adverse long-term outcomes in AKI patients

Urinary levels of novel biomarkers linked to adverse long-term outcomes in AKI patients

High levels of two novel urinary biomarkers early in critical illness are associated with adverse long-term outcomes in patients with acute kidney injury (AKI), according to an international, multi-center study led by University of Pittsburgh School of Medicine Researchers. [More]
Intrexon and ZIOPHARM Oncology sign exclusive licensing agreement with MD Anderson

Intrexon and ZIOPHARM Oncology sign exclusive licensing agreement with MD Anderson

Intrexon Corporation, a leader in synthetic biology and its oncology partner, ZIOPHARM Oncology, today announced a broad exclusive licensing agreement with The University of Texas MD Anderson Cancer Center, including an exclusive sublicensing agreement through MD Anderson for intellectual property developed at the University of Minnesota for the development of non-viral adoptive cellular cancer immunotherapies. [More]
Women & Infants Hospital of Rhode Island receives 2015 Women's Choice Award

Women & Infants Hospital of Rhode Island receives 2015 Women's Choice Award

Today it was announced that Women & Infants Hospital of Rhode Island, a Care New England Hospital, has received the 2015 Women's Choice Award as one of America's Best Hospitals for Obstetrics. This evidence-based designation identifies the country's best health care institutions based on robust criteria that consider female patient satisfaction, clinical excellence and what women say they want from a hospital. [More]
JHQ special issue focuses on 'Transitions in Care'

JHQ special issue focuses on 'Transitions in Care'

The current issue of the Journal for Healthcare Quality is devoted entirely to an increasingly significant concern in healthcare quality management - how to assure favorable outcomes when transitioning patients from one clinical environment to another or to the home. [More]
Better physical functioning associated with remission of general anxiety, PTSD symptoms

Better physical functioning associated with remission of general anxiety, PTSD symptoms

In a two-year longitudinal study involving 13 intensive care units in four U.S. hospitals, researchers found that better physical functioning — basic and complex activities considered essential for maintaining independence — is associated with remission of general anxiety and post-traumatic stress disorder (PTSD) symptoms. These findings may help clinicians be better prepared for caring for the growing number of survivors of critical illness, potentially leading to a better quality of recovery for patients. [More]
Loyola to be included in "Guinness World Records" 2015 edition for neonatal care

Loyola to be included in "Guinness World Records" 2015 edition for neonatal care

Loyola University Medical Center will be included in the "Guinness World Records" 2015 edition for caring for the world's smallest baby. [More]
FDA receives IDE application for CytoSorbents' CytoSorb cardiac surgery trial

FDA receives IDE application for CytoSorbents' CytoSorb cardiac surgery trial

CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced today that it has submitted an Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to conduct its proposed clinical trial using CytoSorb® intra-operatively in patients undergoing complex cardiac surgery requiring the use of a heart-lung machine. [More]
Former baseball player describes his journey in diabetes management

Former baseball player describes his journey in diabetes management

Former professional player Dmitri Young impressed the baseball world when he appeared at a game this summer, having lost about 100 pounds since he last played in 2010. [More]
Deeper cooling does not reduce NICU death among newborns with hypoxic ischemic encephalopathy

Deeper cooling does not reduce NICU death among newborns with hypoxic ischemic encephalopathy

Among full-term newborns with moderate or severe hypoxic ischemic encephalopathy (damage to cells in the central nervous system from inadequate oxygen), receiving deeper or longer duration cooling did not reduce risk of neonatal intensive care unit death, compared to usual care, according to a study in the December 24/31 issue of JAMA. [More]

Comprehensive care improves health of high-risk, chronically ill children, reduces hospital costs

High-risk children with chronic illness who received care at a clinic that provided both primary and specialty care and features to promote prompt effective care had an increase in access to care and parent satisfaction and a reduction in serious illnesses and costs, according to a study in the December 24/31 issue of JAMA. [More]
CorMedix signs Neutrolin sales/distribution agreement with Arabian Trade House

CorMedix signs Neutrolin sales/distribution agreement with Arabian Trade House

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, announced today the first signed Middle East sales/distribution agreement for lead product Neutrolin with distributor Arabian Trade House in the Kingdom of Saudi Arabia. [More]

CytoSorbents starts trading on The Nasdaq Capital Market

CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced that it will commence trading today on The Nasdaq Capital Market under its current ticker symbol "CTSO". [More]